| Rhonda Eckhart, RPT | |
|
500 Park St E, Annandale, MN 55302-3060 | |
| (763) 689-5385 | |
| Not Available |
| Full Name | Rhonda Eckhart |
|---|---|
| Gender | Female |
| Speciality | Physical Therapist |
| Location | 500 Park St E, Annandale, Minnesota |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1538260062 | NPI | - | NPPES |
| HP34778 | Other | MN | HEALTH PARTNERS |
| 725T2EC | Other | MN | BLUE CROSS BLUE SHIELD |
| 6406148 | Other | MN | MEDICA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 225100000X | Physical Therapist | 4432 (Minnesota) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Rhonda Eckhart, RPT 20803 County Road 50, Big Lake, MN 55309-9389 Ph: () - | Rhonda Eckhart, RPT 500 Park St E, Annandale, MN 55302-3060 Ph: (763) 689-5385 |
News Archive
New York University Sociologist Troy Duster concludes that a pharmaceutical to combat heart disease among blacks is based on faulty research and urges the Food and Drug Administration to obtain more reliable data before approving the drug.
On the eve of World AIDS Day 2009, AIDS Healthcare Foundation (AHF) praised the World Health Organization (WHO) for its new HIV treatment recommendations which include starting lifesaving antiretroviral treatment (ART) earlier (at a t-cell count of <350 cells/mm3 instead of <200) for all HIV-positive adults and adolescents and earlier treatment initiation for HIV-positive pregnant women who should now begin treatment at 14 weeks into pregnancy, rather than 28 weeks as previously recommended, and continue until the end of breastfeeding.
The near inevitability that influenza will explode into a pandemic in the coming few years has kept researchers searching for a way to prevent the worst effects of infection. The ultimate prize is a highly effective vaccine that could be produced and deployed rapidly.
No one wants to hear the words, "you have colon cancer." For patients diagnosed with an advanced form of the disease, these words can be particularly devastating. The five-year survival rate can be a little as 6 percent. The top-of-mind question becomes, "Which treatment or clinical trial will work for me?"
Clementia Pharmaceuticals, Inc. today announced that it has secured an additional $10 million from current investors to support development of the company's lead compound palovarotene for the treatment of fibrodysplasia ossificans progressive (FOP).
› Verified 8 days ago
Ann Gross, Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 500 Park St E, Annandale, MN 55302 Phone: 320-274-2394 | |
Mr. Eric Richard Heimkes, MPT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 64 Myrtle Ave S, Annandale, MN 55302 Phone: 320-224-1142 | |
David Gerald Hanson, PT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 500 Park St E, Annandale, MN 55302 Phone: 320-274-2394 | |
Alexandra Kathleen Bangasser, PT Physical Therapist Medicare: Medicare Enrolled Practice Location: 500 Park St E, Annandale, MN 55302 Phone: 320-274-2394 |